ResearcherUniversity of CologneNo recent work listed

Heike Löser

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4555-1327; OpenAlex author ID A5088294178, A5108624419. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13112689 ↗
First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report. Co-author DOI 10.1186/s12885-018-5151-6 ↗
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target. Co-author DOI 10.3892/mco.2017.1194 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alexander Quaas · 3 shared papers, 2017–2021 · strength 0.29
Christiane J. Bruns · 2 shared papers, 2018–2021 · strength 0.22
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689 ↗
- Paper First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case … DOI 10.1186/s12885-018-5151-6 ↗
Alexander Ioannis Damanakis · 1 shared paper, 2021 · strength 0.12
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689 ↗
Felix Popp · 1 shared paper, 2021 · strength 0.12
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689 ↗
Philipp Lohneis · 1 shared paper, 2021 · strength 0.12
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689 ↗
Jiahui Li · 1 shared paper, 2021 · strength 0.12
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689 ↗
Yue Zhao · 1 shared paper, 2021 · strength 0.12
- Paper Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13112689 ↗
Denise Buchner · 1 shared paper, 2018 · strength 0.10
- Paper First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case … DOI 10.1186/s12885-018-5151-6 ↗
Markus P. Ghadimi · 1 shared paper, 2018 · strength 0.10
- Paper First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case … DOI 10.1186/s12885-018-5151-6 ↗
Dirk Waldschmidt · 1 shared paper, 2017 · strength 0.07
- Paper Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target. DOI 10.3892/mco.2017.1194 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.